ArticleCancer management and research2018

Bevacizumab combined with chemotherapy vs single-agent therapy in recurrent glioblastoma: evidence from randomized controlled trials.

Zhouqing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.